Factors Associated With Improved Survival Among Young Adult Melanoma Patients Despite a Greater Incidence of Sentinel Lymph Node Metastasis

Journal of Surgical Research

Volumn 143, Issue 1, 2007, Pages 164-168

  Chagpar, Ryaz B ^b   Ross, Merrick I ^c   Reintgen, Douglas S ^d   Edwards, Michael J ^e   Scoggins, Charles R ^a   Martin II, Robert C G ^a   Noyes, R Dirk ^f   Goydos, James S ^g   Beitsch, Peter D ^h   Urist, Marshall M ⁱ   Ariyan, Stephan ^j   Davidson, B Scott ^k   Sussman, Jeffrey J ^l   McMasters, Kelly M ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d Lakeland Regional Cancer Center   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^f LDS HOSPITAL   (United States)

^g ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^h Dallas Surgical Group   (United States)

ⁱ Kentucky   (United States)

^j YALE CANCER CENTER   (United States)

^k Albany Surgical PC   (United States)

^l UNIVERSITY OF CINCINNATI   (United States)

more..

Author keywords

age; melanoma; prognostic factors; sentinel lymph node; survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CONTROLLED STUDY; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALIGNANT LENTIGO; MELANOMA; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SENTINEL LYMPH NODE; SURVIVAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SEX CHARACTERISTICS; SKIN NEOPLASMS;

EID: 35348893395     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.04.004     Document Type: Article

References (22)

1. Balch C.M., Soong S.J., Gershenwald J.E., et al. Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19 (2001) 3622
2. Austin P.F., Cruse C.W., Lyman G., et al. Age as a prognostic factor in the malignant melanoma population. Ann Surg Oncol 1 (1994) 487
3. Statius Muller M.G., van Leeuwen P., de Lange-de Klerk E., et al. The sentinel lymph node status is an important factor predicting clinical outcome in patients with stage I or II cutaneous melanoma. Cancer 91 (2001) 2401
4. McMasters K.M., Wong S.L., Edwards M.J., et al. Factors that predict the presence of sentinel lymph metastasis in patients with melanoma. Surgery 130 (2001) 151
5. McMasters K.M., Reintgen D.S., Ross M.I., et al. Sentinel lymph node biopsy for melanoma: How many radioactive nodes should be removed?. Ann Surg Oncol 8 (2001) 192
6. Schuchter L., Schultz D.J., Synnestvedt M., et al. A prognostic model for predicting 10-year survival in patients with primary melanoma. Ann Intern Med 125 (1996) 369
7. Chao C., Martin R.C., Ross M.I., et al. Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol 11 (2004) 259
8. McMasters K.M., Noyes R.D., Reintgen D.S., et al. Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol 86 (2004) 212
9. Loggie B., Ronan S.G., Bean J., et al. Invasive cutaneous melanoma in elderly patients. Arch Dermatol 127 (1991) 1188
10. Scoggins C.R., Ross M.I., Reintgen D.S., et al. Gender-related differences in outcome for melanoma patients. Ann Surg 243 (2006) 693
11. Clary B.M., Brady M.S., Lewis J.J., et al. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: Review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 233 (2001) 250
12. Essner R., Conforti A., Kelley M.C., et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 6 (1999) 442
13. Richardson B., Price A., Wagner M., et al. Investigation of female survival benefit in metastatic melanoma. Br J Cancer 80 (1999) 2025
14. Demierre M.F. Thin melanoma and regression, thick melanomas and older men. Arch Dermatol 138 (2002) 678
15. Guitart J., Lowe L., Peipkorn M., et al. Histological characteristics of metastasizing thin melanomas. Arch Dermatol 138 (2002) 603
16. Caracò C., Marone U., Botti G., et al. Age as predictor in patients with cutaneous melanoma submitted to sentinel lymph node biopsy. Eur J Surg Oncol 32 (2006) 970
17. Carlson G.W. Age and the incidence of sentinel lymph node metastases in melanoma. Ann Surg Oncol 11 (2004) 236
18. Carlson G.W., Murray D.R., Lyles R.H., et al. The amount of metastatic melanoma in a sentinel lymph node: Does it have a prognostic significance?. Ann Surg Oncol 10 (2003) 575
19. Ranieri J.M., Wagner J.D., Azuaje R., et al. Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel lymph node biopsy. Ann Surg Oncol 9 (2002) 975
20. Sondak V.K., Taylor J.M.G., Sabel M.S., et al. Mitotic rate and younger age are predictors of sentinel lymph node positivity: Lessons learned from the generation of a probabilistic model. Ann Surg Oncol 11 (2004) 247
21. Thompson J.F., and Shaw H.M. Should tumor mitotic rate and patient age, as well as tumor thickness, be used to select melanoma patients for sentinel node biopsy?. Ann Surg Oncol 11 (2004) 233
22. Paek S.C., Griffith K.A., Johnson T.M., et al. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. Cancer 109 (2007) 100